Document:

<Page>
                                                                   EXHIBIT 10.32

            FIRST AMENDMENT TO COMMON STOCK PURCHASE AGREEMENT

THIS FIRST AMENDMENT TO COMMON STOCK PURCHASE AGREEMENT (the "Amendment"), dated
as of August 10, 2007, by and between AETHLON MEDICAL, INC., a Nevada
corporation (the "Company"), and FUSION CAPITAL FUND II, LLC (together with its
permitted assigns, the "Buyer"). Capitalized terms used herein and not otherwise
defined herein shall have the meanings given them in the Common Stock Purchase
Agreement.

WHEREAS, the parties hereto are parties to a Common Stock Purchase A greement
dated as of March 21, 2007 (the "Common Stock Purchase Agreement") pursuant to
which the Buyer has agreed to purchase, and the Company has agreed to sell up to
$8,400,000 of the Common Stock;

WHEREAS, the parties desire to amend and restate certain provisions of the
Common Stock Purchase Agreement;

NOW, THEREFORE, in consideration of the agreements, covenants and considerations
contained herein, the parties hereto agree as follows:

Amendments. The following Sections of the Common Stock Purchase Agreement are
hereby amended as follow:

Section 4(a) of the Common Stock Purchase Agreement is hereby amended and
restated in its entirety as follows:

"(a) Filing of Form 8-K and Registration Statement. The Company agrees that it
shall, within the time required under the 1934 Act file a Report on Form 8-K
disclosing this Agreement and the transaction contemplated hereby. The Company
shall also file within ten (10) Business Days from the date hereof a new
registration statement covering only the sale of the Commitment Shares and
7,333,333 Purchase Shares (which includes the 1,333,333 Initial Purchase Shares)
in accordance with the terms of the Registration Rights Agreement between the
Company and the Buyer, dated as of the date hereof ("Registration Rights
Agreement")."

Section 11(k)(iv) of the Common Stock Purchase Agreement is hereby amended
and restated in its entirety as follows:

"(iv) If by the Maturity Date for any reason or for no reason the full Available
Amount under this Agreement has not been purchased as provided for in Section 1
of this Agreement, this Agreement shall automatically terminate on the Maturity
Date, without any action or notice on the part of any party and without any
liability whatsoever of any party to any other party under this Agreement."

Effect of Amendment/Incorporation of Certain Provisions. Except as amended as
set forth above, the Common Stock Purchase Agreement shall continue in full
force and effect. The provisions set forth in Section 11 of the Common Stock
Purchase Agreement are hereby incorporated by reference into this Amendment.

                                    * * * * *

IN WITNESS WHEREOF, the Buyer and the Company have caused this First Amendment
to Common Stock Purchase Agreement to be duly executed as of the date first
written above.

THE COMPANY:

AETHLON MEDICAL, INC.

By: /s/ James A Joyce
    ----------------------------
    Name: James A Joyce
    Title: Chairman and Chief Executive Officer

BUYER:

FUSION CAPITAL FUND II, LLC
BY: FUSION CAPITAL PARTNERS, LLC
BY: SGM HOLDINGS CORP.

By: /s/ Steven J. Martin
    ---------------------------
    Name: Steven G. Martin
    Title: President<PAGE>

EXHIBIT 10.1

                              ASSIGNMENT AGREEMENT
                              --------------------

THIS ASSIGNMENT AGREEMENT {this "AGREEMENT"), is made on APRIL 16, 2007, (the
"EFFECTIVE DATE") CORNELL CAPITAL PARTNERS, L.P. a Cayman Islands exempt Limited
Partnership, with its principal place of business at 101 Hudson Street, Suite
3700, Jersey City, NJ 07302 (the "ASSIGNOR"), and ACUNETX, INC., a registered
Nevada corporation with its principal place of business at 1000 South McCaslin,
Suite 300, Superior, CO 80027 (the "ASSIGNEE").

         WHEREAS, Assignor is the legal and beneficial owner of that certain
Five Hundred Ten Thousand Nine Hundred Seventy Eight 510,978) restricted shares,
certificate number 20348-9, dated February 1, 2007 ("Restricted Shares") and
Seventy Thousand (70,000) common shares ("COMMON SHARES" ) (collectively
"SHARES") of AcuNetx, Inc. (the "COMPANY"), which was acquired by the Assignor
through its rights under a Standby Equity Distribution Agreement "SEDA"), dated
January 31, 2006, including without limitation the Registration Rights Agreement
and Placement Agent Agreement, each dated January 31, 2006 (collectively
"TRANSACTION DOCUMENTS");

         WHEREAS, Assignor desires to assign to Assignee and Assignee desires to
purchase from Assignor the Shares on the basis of the representations,
warranties and agreements contained in this Agreement, and upon the terms but
subject, to the conditions set forth herein; and

         NOW, THEREFORE, in consideration of the foregoing and for other good
and valuable consideration, the adequacy of which is hereby acknowledged, the
parties hereto agree as follows:

         1) ASSIGNMENT. For the Purchase Price equal to the amount set forth on
SCHEDULE I attached hereto, the Assignor hereby absolutely, irrevocably and
unconditionally sells, assigns, conveys, contributes and transfers to the
Assignee the Shares and all of its rights and benefits thereunder and conferred
therein and the Assignee accepts such assignment as of the date hereof, This
assignment is made free and clear of any and all claims, liens, demands,
restrictions or encumbrances of any kind whatsoever.

         2) DELIVERY OF SHARES, CLOSING The sale and transfer of the Shares as
herein contemplated and all actions required to be completed hereunder shall
take place on a date and time agreeable to the parties hereto but in no event
after twenty-one (21) days from the Effective Date (the "CLOSING DATE"). On the
Closing Date the Assignee shall pay to the Assignor the full Purchase Price in
immediately available funds in US Dollars and upon receipt of the Purchase Price
the Assignor shall deliver to the Assignee the Shares which are the subject of
this Agreement duly endorsed for transfer to the Assignor.

         3) ADDITIONAL DOCUMENTS. The Assignor agrees to take such further
action and to execute and deliver, or cause to be executed and delivered, any
 other documents which are, in the opinion of the Assignee or its counsel,
necessary to carry out the terms and conditions of this Assignment.

         4) EFFECTIVE DATE AND COUNTERPART SIGNATURE. This Agreement shall be
effective as of the date first written above. This Agreement, and acceptance of
same, may be executed in one or more counterparts, each of which shall be deemed
an original, but all of which together shall constitute one and the same
instrument.

<PAGE>

Confirmation of execution by telex or by telecopy or telefax of a facsimile
signature page shall be binding upon that party so confirming.

         5) REPRESENTATIONS AND WARRANTIES OF THE ASSIGNOR. The Assignor hereby
warrants and represents as follows:

                  a) ORGANIZATION; AUTHORITY The Assignor is an entity duly
organized, validly existing and in good standing under the laws of the
jurisdiction of its organization with full right, corporate, partnership or
other applicable power and authority to enter into and to consummate the
transactions contemplated by this Agreement and otherwise to carry out its
obligations thereunder; and the execution, delivery and performance by the
Assignor of the transactions contemplated by this Agreement have been duly
authorized by all necessary corporate, partnership or similar action on the part
of the Assignor. This Agreement, when executed and delivered by the Assignor,
will constitute a valid and legally binding obligation of the Assignor,
enforceable against the Assignor in accordance with its terms, except (a) as
limited by applicable bankruptcy, insolvency, reorganization, moratorium,
fraudulent conveyance, and any other laws of general application affecting
enforcement of creditors' rights generally, (b) as limited by laws relating to
the availability of specific performance, injunctive relief, or other equitable
remedies, or (c) to the extent the indemnification provisions contained herein
may be limited by federal or state securities laws.

                  b) OWNERSHIP OF SHARES. Assignor is the sole owner and holder
of the Shares to be transferred hereby. There are no liens, claims or
encumbrances affecting any of the shares except with respect to restrictions on
the further transfer of the Shares as may be imposed by the Securities Act of
1933, as amended. The Shares have been held by the Assignor exclusively since
their acquisition and the Assignor has not pledged or created any lien, with
respect to any of the Shares during the term of its ownership of the Shares.

                  c) NO LITIGATION. There is no action, suit, proceeding,
judgment, claim or investigation pending, or to the knowledge of the Assignor,
threatened against the Assignor which could reasonably be expected in any manner
to challenge or seek to prevent, enjoin, alter or materially delay any of the
transactions contemplated by this Agreement.

                  d) NO CONFLICTS; ADVICE. Neither the execution and delivery of
the this Agreement, nor the consummation of the transactions contemplated
hereby, does or will violate any constitution, statute, regulation, rule,
injunction, judgment, order, decree, ruling, charge or other restriction of any
government, governmental agency, or court to which the Assignor is subject or
any provision Of its organizational documents Or other similar governing
instruments, or conflict with, violate or constitute a default under any
agreement, credit facility, debt or other instrument or understanding to which
the Assignor is a party. The Assignor has consulted such legal, tax and
investment advisors as it, in its sole discretion, has deemed necessary or
appropriate in connection with the Assignment of the Shares, e) CONSENTS. No
authorization, consent, approval or other order of, or declaration to or filing
with, any governmental agency or body or other person is required for the valid
authorization, execution, delivery and performance by the Assignor of this
Agreement and the consummation of the transactions contemplated hereby.

         6) REPRESENTATIONS AND WAR TIES OF THE ASSIENEE.

                  a) ORGANIZATION; AUTHORITY, The Assignee, if not a natural
person, is an entity duly organized, validly

                                      -2-

<PAGE>

existing and in good standing under the laws of the jurisdiction of its
organization with full right, corporate, partnership or other applicable power
and authority to enter into and to consummate the transactions contemplated by
this Agreement and otherwise to carry out its obligations thereunder, and the
execution, delivery and performance by the Assignee of the transactions
contemplated by this Agreement have been duly authorized by an necessary
corporate or similar action on the pall of the Assignee. This Agreement, when
executed and delivered by the Assignee, will constitute a valid and legally
binding obligation of the Assignee, enforceable against the Assignee in
accordance with its terms, except (a) as limited by applicable bankruptcy,
insolvency., reorganization, moratorium, fraudulent conveyance, and any ether
laws of general application affecting enforcement of creditors' rights
generally, (b) as limited by laws resting to the availability of specific
performance, injunctive relief, or other equitable remedies, or (c) to the
extent the indemnification provisions contained herein may be limited by federal
or state securities laws.

                  b) INVESTMENT LATENT. The Assignee is acquiring the Shares for
investment for his own account, not as a nominee or agent, and not with a view
to, or for sale in connection with, any distribution, resale or public offering
of such Shares or any part thereof in violation of the United States Securities
and Exchange Act of 1933, as amended ("SECURITIES ACT"). The Assignee does not
presently have any contract, undertaking, agreement or arrangement with any
entity, organization or individual (each a "PERSON") to sell, transfer or grant
participations to any Person with respect to the Shares.

                  c) INVESTMENT EXPERIENCE; ACCESS TO INFORMATION AND
PREEXISTING RELATIONSHIP. The Assignee (a) either alone or together With its
representatives, has such knowledge and experience, in financial and business
matters as to he capable of evaluating the merits, and risks of this investment
and make an informed decision to so invest, and has so evaluated the risks and
merits of such investment, (b) has the ability to hear the economic risks of
this investment and can afford a complete loss of such investment, (c)
understands the terms of and risks associated with the acquisition of the
Shares, including, without limitation, a lack of liquidity, price transparency
or pricing availability and risks associated with the industry in which the
Company operates, (d) has had the opportunity to review such disclosure
regarding the Company, its business, its financial condition and its prospects
as the Assignee has determined to he necessary in connection with the Assignment
of the Shares, including, without limitation, the Company's Annual Report on
Form 10-K (or substantially equivalent form) for its most recently completed
fiscal year, the Company's Quarterly Reports on Form 10-Q (or substantially
equivalent form) for the fiscal quarters since the end of such completed fiscal
year, and the Company's Current Reports on Form 8-K (or substantially equivalent
form) since the end of such completed fiscal year. each as amended.

                  d) ASSIGNEE STATUS. At the time the Assignee was offered the
Shares, it was, and as of the date hereof it is, an "ACCREDITED INVESTOR" as
that term is defined in Rule 501(a) of Regulation D under the Securities Act.
The Assignee is not, and is not required to be registered as, a broker-dealer
under Section 15 of the United States Securities and Exchange Act of 1934
("EXCHANGE ACT").

                  e) RESTRICTIONS ON TRANSFER. The Assignee understands that the
Restricted Shares (a) have not been registered under the Securities Act or the
securities laws of any state, (b) are and will be "RESTRICTED SECURITIES" as
said term is defined in Rule 144 of the Rules and Regulations promulgated under
the Securities Act ("RULE 144"), (c) may not be sold, pledged or otherwise
transferred unless a registration statement for such transaction is effective
under the Securities Act and any applicable state securities laws, Or unless an
exemption from such registration provisions is available with respect to such
transaction, and (d) will bear a legend substantially as set forth below:

                                      -3-

<PAGE>

         THE SHARES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED
         WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECUMTIES COMMISSION
         OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE
         SECURITIES ACT OE 1933, AS AMENDED (THE "SECURITIES ACT"), AND,
         ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE
         REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN
         AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE,
         REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH
         APPLICABLE STATE SECURITIES LAWS.

                  f) GENERAL SOLICITATION. The Assignee is not accepting such
Assignment as a result of any advertisement, article, notice or other
communication regarding the Shares published in any newspaper, magazine or
similar media or broadcast over television or radio or presented at any seminar
or any other general solicitation or general advertisement.

                  g) NO CONFLICTS; ADVICE. Neither the execution and delivery of
the this Agreement, nor the consummation of the transactions contemplated
hereby, does or will violate any constitution, statute, regulation, rule,
injunction, judgment, order, decree, ruling, charge or other restriction of any
government, governmental agency, or court to which the Assignee is subject or
any provision of its organizational documents or other similar governing
instruments, or conflict with, violate or constitute a default under any
agreement, credit facility, debt or other instrument or understanding to which
the Assignee is a party. The Assignee has consulted such legal, tax and
investment advisors as it, in its sole discretion, has deemed necessary or
appropriate in connection with the Assignment of the Shares.

                  h) NO LITIGATION. There is no action, suit, proceeding,
judgment, claim or investigation pending, or to the knowledge of the Assignor,
threatened against the Assignor which could reasonably be expected in any manner
to challenge or seek to prevent, enjoin, alter or materially delay any of the
transactions contemplated by this Agreement.

                  i) CONSENTS. No authorization, consent, approval or other
order of, or declaration to or filing with, any governmental agency or body or
other person is required for the valid authorization, execution, delivery and
performance by the Assignor of this Agreement and the consummation of the
transactions contemplated hereby.

                  j) The Assignee hereby acknowledges that the Shares may only
be disposed of in compliance with United States Federal and State Securities
Laws. The Assignee further acknowledges that in connection with any transfer of
the Shares subsequent to the date hereof and other than pursuant to an effective
registration statement, the Company and/or the Company's transfer agent may
require an opinion of counsel, the form and substance of which opinion shall be
reasonably satisfactory to the Company and/or the Company's transfer agent, as
applicable,

                  k) STOP TRANSFER NOTICES. The Assignee agrees that, in order
to ensure compliance with the restrictions referred to herein, appropriate "STEP
TRANSFER" instructions may be issued to the Company's transfer agent.

                                      -4-

<PAGE>

         7) GOVERNING LAW; SUBMISSION TO JURISDICTION, THIS AGREEMENT SHALL BE
GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW
JERSEY, WITHOUT REGARD TO CONFLICT OF LAW PRINCIPLES. EACH PARTY AGREES THAT ANY
ACTION OR PROCEEDING ARISING OUT OF OR RELATING IN ANY WAY TO THIS AGREEMENT
SHALL BE BROUGHT IN A U.S. FEDERAL OR STATE COURT OF COMPETENT JURISDICTION
SITTING IN THE HUDSON COUNTY, IN THE STATE OF NEW JERSEY. EACH PARTY HEREBY
IRREVOCABLY AND UNCONDITIONALLY CONSENTS TO THE JURISDICTION OF SUCH COURT AND
HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY DEFENSE OF AN INCONVENIENT
FORUM OR A LACK OF PERSONAL JURISDICTION TO THE MAINIENANCE OF ANY ACTION OR
PROCEEDING AND ANY RIGHT OF JURISDICTION OR VENUE ON ACCOUNT OF THE PLACE OF
RESIDENCE OR DOMICILE OF ANY PARTY HERETO. EACH PARTY HEREBY IRREVOCABLY WAIVES
ANY RIGHT IT MAY HAVE, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE
ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH OR ARISING OUT OF
I'HIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY.

         8) AMENDMENTS. No provision hereof may be waived or modified other than
by an instrument in writing signed by the party against whom enforcement is
sought.

         9) SEVERABILITY. If any provision of this Agreement shall be invalid or
unenforceable in any jurisdiction, such invalidity or unenforceability shall not
affect the validity or enforceability of the remainder of this Agreement in that
jurisdiction or the validity or enforceability of any provision, of this
Agreement in any other jurisdiction.

         10) WAIVER AND CONSENT. The Company hereby waives compliance with 2(f)
of the Securities Purchase Agreement in connection with this Agreement and
consents to the assignment of the Shares and all rights and interests that the
Assignor has under the Transaction Documents from the Assignor to the Assignee.

                     [SIGNATURE PAGE TO IMMEDIATELY FOLLOW]

                                      -5-

<PAGE>

         IN WITNESS WHEREOF. the parties hereto have executed this Agreement the
day and year first above written.

ASSIGNOR
--------

CORNELL CAPITAL PARTNERS, L.P.
BY: YORKVILLE ADVISORS, LLC
ITS:  INVESTMENT ADVISOR

By: /S/ MARK ANGELO
    -----------------------------------------------
Name: Mark Angelo
Title: Portfolio Manager

ASSIGNEE
--------

AcuNetx, Inc.

By: /S/ RON WALDORF
    -----------------------------------------------
Name: Ron Waldorf
Title: CEO

COMPANY
-------

Acknowledged and Agreed:
ATIONETX, INC.

By: /S/ RON WALDORF
    -----------------------------------------------
Name: Ron Waldorf
Title: CEO

                                      -6-

<PAGE>

<TABLE>
<S>     <C>

                                                           SCHEDULE I

------------------------------- ----------------------------- ---------------------------------- -------------------------------
        ASSIGNEE NAME                   COMPANY NAME                   NUMBER OF SHARES                 PURCHASE PRICE
------------------------------- ----------------------------- ---------------------------------- -------------------------------
                                                                            510,978
        AcuNetx, Inc.                  AcuNetx, Inc.                  (Restricted Shares)                  $6,387.23
------------------------------- ----------------------------- ---------------------------------- -------------------------------
                                                                            70,000
        AcuNetx, Inc.                  AcuNetx, Inc.                    (Common Shares)                      $875.00
------------------------------- ----------------------------- ---------------------------------- -------------------------------

                                           TOTAL                            580,978                        $7,262.23
------------------------------- ----------------------------- ---------------------------------- -------------------------------

                                                              -7-
</TABLE>

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00128-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00128-of-00352.parquet"}]]